Form 8-K - Current report:
SEC Accession No. 0000950170-25-071988
Filing Date
2025-05-15
Accepted
2025-05-15 07:31:32
Documents
32
Period of Report
2025-05-15
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K pvla-20250515.htm   iXBRL 8-K 51237
2 EX-99.1 pvla-ex99_1.htm EX-99.1 132203
3 EX-99.2 pvla-ex99_2.htm EX-99.2 16588
4 GRAPHIC img6060170_0.jpg GRAPHIC 34152
5 GRAPHIC img6060170_1.jpg GRAPHIC 34152
6 GRAPHIC img6060170_2.jpg GRAPHIC 34152
7 GRAPHIC pvla-ex99_2s1.jpg GRAPHIC 253336
8 GRAPHIC pvla-ex99_2s2.jpg GRAPHIC 810626
9 GRAPHIC pvla-ex99_2s3.jpg GRAPHIC 537060
10 GRAPHIC pvla-ex99_2s4.jpg GRAPHIC 356528
11 GRAPHIC pvla-ex99_2s5.jpg GRAPHIC 389450
12 GRAPHIC pvla-ex99_2s6.jpg GRAPHIC 177139
13 GRAPHIC pvla-ex99_2s7.jpg GRAPHIC 363187
14 GRAPHIC pvla-ex99_2s8.jpg GRAPHIC 490589
15 GRAPHIC pvla-ex99_2s9.jpg GRAPHIC 365590
16 GRAPHIC pvla-ex99_2s10.jpg GRAPHIC 404783
17 GRAPHIC pvla-ex99_2s11.jpg GRAPHIC 173959
18 GRAPHIC pvla-ex99_2s12.jpg GRAPHIC 341304
19 GRAPHIC pvla-ex99_2s13.jpg GRAPHIC 333006
20 GRAPHIC pvla-ex99_2s14.jpg GRAPHIC 139236
21 GRAPHIC pvla-ex99_2s15.jpg GRAPHIC 280533
22 GRAPHIC pvla-ex99_2s16.jpg GRAPHIC 145621
  Complete submission text file 0000950170-25-071988.txt   8151575

Data Files

Seq Description Document Type Size
23 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT pvla-20250515.xsd EX-101.SCH 41897
34 EXTRACTED XBRL INSTANCE DOCUMENT pvla-20250515_htm.xml XML 4505
Mailing Address 125 STRAFFORD AVE SUITE 360 WAYNE PA 19087
Business Address 125 STRAFFORD AVE SUITE 360 WAYNE PA 19087 (484) 253-1461
PALVELLA THERAPEUTICS, INC. (Filer) CIK: 0001583648 (see all company filings)

EIN.: 300784346 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37471 | Film No.: 25948720
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)